博文
爱思唯尔51种期刊影响因子列该领域第一
||
最近，爱思唯尔公司发布了一则新闻稿，宣布了旗下期刊2008年影响因子的有关情况。
---- 在JCR公布的229个领域里，爱思唯尔期刊在51个领域里拔得头筹，影响因子列第一。
---- 爱思唯尔75%的期刊影响因子比2007年有所上升。
---- 爱思唯尔有30种新创办的期刊首次有了影响因子。其中几个期刊表现非凡：
（1）Cell Stem Cell的第一个影响因子就很高（16.826），跻身Cell Biology 领域第6位。
（2）Cell Host & Microbe影响因子7.436，列Microbiology领域第10位。
（3）Materials Today影响因子12.929, 列Materials Science, Multidisciplinary领域第4位。
爱思唯尔期刊影响因子的上升，标志着期刊整体质量的提高。在科学分类的领域里，影响因子不失为衡量期刊质量的一个有用参数。请注意，这里说的是期刊的质量。至于论文，发表在高影响因子的期刊上，并不意味着就是同行认可的高质量的论文。
前几天科学网上关于SCI有热烈的争论。我关注着这些争论，觉得有些老师说得非常有道理，我作为后学，没有什么可以补充的。而且，我也不便在博客里评论同行的产品。
但我觉得值得关注的一个现象是：像爱思唯尔这样的大型出版集团（当然包括其它外国出版集团），因为背后的实力（经济实力、管理经验和业界知名度），它们能够在创办新刊后，迅速地提高刊物的影响力。上述3种期刊就是证明，它们能够在第一次获得影响因子后，就跻身该领域的前列，这是非常不容易的。
我想有可能的话，以后会请这几种期刊的出版人或主编来中国，与中国期刊界的同行交流一下，讨论如何尽快提高刊物的影响力。欢迎有兴趣的期刊界同行与我们联系，由你们出面来邀请，我这些外国同事的兴趣可能会更大一些。
详细情况请见下面英文新闻稿：
Elsevier Announces 2008 Journal Impact Factor Highlights
51 Elsevier journals receive top rank and show continued focus on quality
Amsterdam, 29 June 2009 – Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the highlights of its journal impact factor performance in 2008. Elsevier overall saw 75% of its journal impact factors (IF) increase from 2007 to 2008. According to the 2008 Journal Citation Report® published by ThomsonReuters, Elsevier journals took the #1 position in 51 categories (of 229 in total) across all of the sciences and social sciences.
In addition, 30 Elsevier journals got their first IF this year. Some of these journals received very impressive scores including two Cell Press journals: Cell Stem Cell (http://www.cell.com/cell-stem-cell/home) (16.826) entered the Cell Biology category ranked 6th (of 157 journals), while Cell Host & Microbe (http://www.cell.com/cell-host-microbe/home) (7.436) entered the Microbiology category ranked10th (of 91 journals). Another impressive result in its first year is Materials Today (http://www.materialstoday.com/) (12.929), which is ranked 4th in the Materials Science, Multidisciplinary category (of 191 journals).
This year there were 182 Elsevier journals that increased their IF by more than 50% over their 2007 scores. All three The Lancet speciality journals improved their IF this year. The Lancet Infectious Diseases (http://www.thelancet.com/journals/laninf/issue/current) increased to 13.165, placing it at the #1 position in the Infectious Diseases category. The Lancet Oncology (http://www.thelancet.com/journals/lanonc/issue/current) rose to 13.283, an increase of over 1 full IF point from the 2007 IF. Finally, The Lancet Neurology (http://www.thelancet.com/journals/laneur/issue/current) increased by 40% to 14.270, thereby retaining the #1 position in the Clinical Neurology category for the 5th year running.
Other Elsevier journals continue their long-running trend of increased IFs, in particular Biomaterials (http://www.elsevier.com/locate/biomaterials) (increasing yearly since 2003) and The Journal of Allergy and Clinical Immunology (http://www.elsevier.com/locate/jaci) which has shown consistent growth over the past five years.
Glen Campbell, Senior Vice President of U.S. Health Sciences Journals said, "Each annual announcement of impact factors confirms the depth and excellence of our health sciences journal publishing program. The superior performance of so many of our journals this year is a sign of the strong partnerships we have with our journal editors and our societies. This year's impact factor growth is one indication of the hard work and focus on quality of these collaborations."
“The fact that Elsevier’s overall results are amongst the best in the industry is a true indication of the impact of the increased focus on quality we have placed on our journals in the past three years. The increased impact factors, across the board, are evidence that the research we publish is of the highest quality,” remarked Martin Tanke, Managing Director of Science and Technology Journals. “We are grateful for our strong network of editors we partner with, who work with us each day to build our journals to some of the best in their fields.”
The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year. The impact factor helps to evaluate a journal’s relative importance, especially when compared with others in the same field.
# # #
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media Contact:
Shira Tabachnikoff
Elsevier
+31 20 485 2736
s.tabachnikoff@elsevier.com
https://blog.sciencenet.cn/blog-3686-240896.html
上一篇：偷得浮生半日闲
下一篇：通过Procedia免费获取国际会议录的文章
